EDWARD MAXWELL: Open Payments
NPI 1710119425 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$147 in 2 payments from 2 companies in 2025. Trend: 2023 $0 · 2024 $24 · 2025 $147
Food & beverage: $147
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $124 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $23 |
Products named: CAPLYTA, ABILIFY MAINTENA.
Industry payments across CA — which companies pay providers there.
